license Sandoz generic brands in Africa for $12 million upfront
Published on: March 17, 2026, 7:09 p.m. | Source: CNBC TV18
Strides Pharma Science, through its step-down subsidiary Strides Pharma International AG, has entered into agreements with Sandoz to acquire and in-license branded generic products across Sub-Saharan Africa for an upfront sum of $12 million, along with royalty payments, with Strides Pharma Global Pte. Limited (SPG), providing corporate guarantees.
